Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis
Trial details
- Registry ID
- NCT06585202
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic DermatitisNCT06585202 | ACRS | Phase 2 | Completed | 2025-03-13Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |